Evidence map›Paper›PMID 39874258›Full record

Trial reportPloS one2025

Does opting in or out affect the take up of incentives in a long running population-based cohort study: A nested randomised trial in ALSPAC.

Kate Northstone, Claire Bowring

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kate NorthstonePopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Claire BowringPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundFinancial incentives may be important for improving response rates to data collection activities and for retaining participants in longitudinal studies. However, for large studies, this introduces significant additional costs. We sought to determine whether an opt-in or an opt-out option for receiving financial incentives when completing questionnaires offers any cost saving measures.

methodsThe Avon Longitudinal Study of Parents and Children has been ongoing for more than 30 years. It has offered a £10 incentive for returning a partly or fully completed annual questionnaire for >10 years, this is provided by default unless a participant chooses to opt out. For questionnaires completed in 2020 by the original parents recruited to the study and by their offspring, we randomised eligible participants to either opt-out or to opt-in to receiving their vouchers. Logistic regressions determined whether opt-out or opt-in made any difference to the proportion of respondents receiving their vouchers.

resultsRespondents are less likely to choose to receive a thank you for their time in the form of a £10 shopping voucher if they are asked to opt in compared to if they are asked to opt out. The odds ratio, adjusted for baseline characteristics was 3.94 (95% Confidence Interval: 3.49, 4.45). There was no difference in response rates according to whether respondents were randomised to the opt-in or opt-out group.

conclusionsALSPAC now employs an opt-in procedure for respondents receiving their financial incentive when completing a questionnaire. We recommend similar studies that rely on volunteers consider this option if they want to introduce some cost savings without harming overall response rates.

Indexed as

MotivationAdultCohort StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedSurveys and Questionnaires

Identifiers

PMID39874258
PMCPMC11774395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.